Filling the gaps in the global prevalence map of clinical antimicrobial resistance

  06 January 2021

While antimicrobial resistance is an urgent global problem, substantial clinical surveillance gaps exist in low- and middle-income countries (LMICs). We fill the gaps in the global prevalence map of nine pathogens, resistant to 19 (classes of) antibiotics (representing 75 unique combinations), based on the robust correlation between countries’ socioeconomic profiles and extensive surveillance data. Our estimates for carbapenem-resistant Acinetobacter baumannii and third-generation cephalosporin-resistant Escherichia coli benefit over 2.2 billion people in countries with currently insufficient diagnostic capacity. We show how structural surveillance investments can be prioritized based on the magnitude of prevalence estimated (Middle Eastern countries), the relative prevalence increase over 1998 to 2017 (sub-Saharan African countries), and the improvement of model performance achievable with new surveillance data (Pacific Islands).

Further reading: PNAS
Author(s): Rik Oldenkamp,, Constance Schultsz, Emiliano Mancini, Antonio Cappuccio
Effective Surveillance  
Back


Technology Database

Display your AMR Technology, Product and Service

 

Suppliers and Users of Technologies, Products and Services benefit from CAPI.
CAPI (Continuous AMR Partnering Initiative) unites Suppliers and Users worldwide with the aim to add to the curbing of AMR.

 

Read more and make your own Technology Page >>
What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!